An investor group led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc have sold their equity stake in Pharmaceutics International, Inc, a Hunt Valley, ...

A Hunt Valley drug manufacturing company with more than 300 employees has been acquired by a Fortune 500 firm.

A consortium of investors led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc. today announced they have exited their equity stake in Pharmaceutics ...

As competition increases in the area, more health care systems are turning to building freestanding ERs to reach patients and ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii).

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with ...

Jabil Inc., a provider of engineering, manufacturing, and supply chain solutions, has acquired Pharmaceutics International ...

Jabil's (NYSE:JBL) investors will be pleased with their incredible 333% return over the last five years ...

Learn more about whether Jabil Inc. or TD SYNNEX Corporation is a better investment based on AAII's A+ Investor grades, which ...